January 12, 2012 Guest post by Dr. John Mandrola I’ve never tried this before: giving some brief snips of an AF symposium, on the fly. Maybe doing so will help me remember. My comments are in italics. Little proofreads—consider these quick notes. First talk: Dr Jalife. Molecular mechanisms AF:Think fibrosis, or the infiltration of scar …
Read MoreAll News
By Christine Welniak Summary: A randomized trial showed that minimally invasive (mini maze) surgical ablation was more effective, but with more complications, than catheter ablation at treating atrial fibrillation patients who had failed a previous catheter ablation or had an enlarged left atrium. Reading time: Approximately 8–10 minutes January 9, 2012 — According to a …
Read MoreBy Mellanie True Hills Summary: The impact of rate control treatment on quality of life for atrial fibrillation patients is the focus of our January Patient Perspective column in EP Lab Digest. Reading time: 4–6 minutes, which includes the article referenced January 5, 2012 — In our January Patient Perspective column in EP Lab Digest, …
Read MoreBy Mellanie True Hills Summary: StopAfib.org unveils the Top Ten Atrial Fibrillation Articles of 2011, indicating that patients are focused on afib stroke prevention and atrial fibrillation procedures. Approximate reading time: 2–4 minutes December 29, 2011 — Yesterday, StopAfib.org announced the first of our 2011 Top Ten Lists, the Top Ten Atrial Fibrillation Videos of …
Read MoreBy Mellanie True Hills Summary: StopAfib.org unveils the Top Ten Atrial Fibrillation Videos of 2011, indicating the priorities of the afib community this year. Approximate reading time: 2 minutes December 28, 2011 — Today, StopAfib.org announces the first of our Top Ten Lists, the Top Ten Atrial Fibrillation Videos of 2011. 2011 Most Viewed Afib …
Read MoreBy Christine Welniak Summary: An FDA advisory panel concluded that the benefits outweighed the risks when using the Synergy bipolar radiofrequency clamp during open heart surgeries for treating persistent and longstanding persistent atrial fibrillation. FDA approval was granted December 16, 2012. Reading time: Approximately 4-6 minutes December 16, 2011 — Update: The Food and Drug …
Read MoreBy Mellanie True Hills December 12, 2011 Summary: One of the newest frontiers in atrial fibrillation catheter ablation is focal and rotor ablation. In this video, Dr. Sanjiv Narayan talks about the results of the FIRM trial that he presented at the American Heart Association Scientific Sessions 2011. Reading and watching time is approximately 6 …
Read MoreBy Jennifer L.W. Fink Summary: The drug apixaban (Eliquis) was shown to be superior to warfarin for atrial fibrillation stroke prevention in a large study that was published in the New England Journal of Medicine. FDA approval of the drug is expected by March 28, 2012. Approximate reading time: 3–5 minutes November 30, 2011 — …
Read MoreBy Mellanie True Hills November 28, 2011 Summary: Atrial fibrillation ablation results vary between women and men according to the poster presented by Dr. John Mandrola at the American Heart Association Scientific Sessions 2011. Reading and watching time is approximately 4 minutes In this video interview at the American Heart Association Scientific Sessions 2011, Dr. …
Read MoreNovember 10, 2011 Summary: Here is the transcript of our October 28 afib community chat with the atrial fibrillation experts at the Cleveland Clinic, which provided a rare opportunity to get answers to the most pressing questions of the afib community. There were too many questions to answer during the chat, but the doctors generously …
Read More